Skip to main content

News

April 07, 2020
Don't miss this special live presentation on Managing Interventional Oncology in the Time of COVID-19, featuring insight by #CIO2020 Course Director, Edward Kim, MD.
July 10, 2018
Researchers conducted a prospective, single-center, double-blind randomized phase III trial that compared stable and unstable water-in-oil emulsions for chemoembolization.
June 28, 2018
The study compared results for patients with caudate HCC who were treated with RFA vs TACE.
June 26, 2018
The combination of sorafenib and transarterial chemoembolization (TACE) for patients with advanced HCC seems feasible and promising, researchers reported.
June 15, 2018
Percutaneous cryoblation ablation may be a reasonable treatment option for patients with clinical stage T1a papillary on renal cell carcinoma (pRCC) and clear-cell RCC (ccRCC), especially for patients with (pRCC).
June 14, 2018
The combination of microwave ablation and cementoplasty may offer patients with extra-spinal metastases a minimally invasive option for pain reduction
June 12, 2018
Researchers hypothesized that inhibition of cancer stem cells in HCC may improve the efficacy of percutaneous thermal ablation, TACE, and TAE.
June 05, 2018
The researchers compared outcomes for patients undergoing RFA for primary left-side vs right-side colorectal cancer.
May 31, 2018
An analysis of 9 studies compared TACE plus iodine-125 seed with TACE alone for patients with HCC.
May 29, 2018
Use of TARE for HCC has been increasing over the past decade, according to a study published in JVIR.
May 22, 2018
Analysis of several pretreatment factors may help predict the prognosis of patients treated with Y-90 radioembolization for liver metastases from colorectal cancer.
Back to Top